Potential risks and benefits of phytoestrogen-rich diets

International Journal for Vitamin and Nutrition Research

Volumn 73, Issue 2, 2003, Pages 120-126

  Cassidy, Aedin ^a  

^a UNILEVER RESEARCH   (United Kingdom)

Author keywords

Bioavailability; Bone; Breast cancer; Heart; Isoflavones; Oestrogen receptors; Safety; Soy

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ISOFLAVONE DERIVATIVE; LIGNAN DERIVATIVE; PHYTOESTROGEN;

BINDING AFFINITY; CANCER PREVENTION; CHEMICAL STRUCTURE; CONFERENCE PAPER; DIETARY INTAKE; ESTROGEN METABOLISM; HUMAN; MENOPAUSE; OSTEOPOROSIS; PROTEIN BINDING; RISK BENEFIT ANALYSIS; SOYBEAN; URINARY EXCRETION;

ANIMALIA; GLYCINE MAX; MAMMALIA;

EID: 0037360821     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.73.2.120     Document Type: Conference Paper

References (33)

1. Setchell, K. D. R. and Cassidy, A. (1999) Dietary isoflavones - biological effects and relevance to human health. Journal of Nutrition 129, 758-767.
2. Cassidy, A. and Faughnan, M. (2000) Dietary phytoestrogens through the lifecycle. Proceedings of the Nutrition Society 59, 489-496.
3. Montano, M. M. and Katzenellenbogen, B. S. (1997) The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antioestrogens. PNAS USA 94, 2581-2586.
4. Coward, L., Barnes, N. C., Setchell, K. D. R. and Barnes, S. (1993) Genistein and daidzein, and their b-glycoside conjugates: anti-tumor isoflavones in soybean foods from American and Asian diets. J. Agric. Food Chem. 41, 1961-1967.
5. Setchell, K. D. R., Lawson, A. M., Borriello, S. P., Harkness, R., Gordon, H., Morgam, D. M. L., Kirk, D. N., Anderson, L. C., Adlercreutz, H. and Axelson, M. (1981) Lignan formation in man - microbial involvement and possible roles in relation to cancer. Lancet 2, 4-8.
6. Setchell, K. D. R., Brown, N. M., Desai, P., Cassidy, A. and Heubi, J. E. (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. Journal of Nutrition 131, 1362-1375.
7. Setchell, K. D. R., Borriello, S. P., Hulme, P., Kirk, D. N. and Axelson, M. (1984) Non-steroidal oestrogens of dietary origin: possible roles in hormone dependent disease. American Journal of Clinical Nutrition 40, 569-578.
8. Thompson, L. U., Robb, P., Serraino, M. (1991). Mammalian production of lignans from various foods. Nutrition and Cancer 16, 43-52.
9. 13C]labelled daidzein and genistein in premenopausal women (in press American Journal of Clinical Nutrition).
10. Faughnan, M. F., Setchell, K. D. R., Zimmer-Nechemias, L. and Cassidy, A. (2003) The effect of varying isoflavone intake on urinary concentrations in premenopausal women (submitted for publication).
11. Adlercreutz, H., Honjo, H. and Higashi, A. (1991) Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. American Journal of Clinical Nutrition 54, 1093-1100.
12. Cassidy, A., Bingham, S. and Setchell, K. D. R. (1994) Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. American Journal of Clinical Nutrition 60, 333-340.
13. Cassidy, A., Bingham, S. and Setchell, K. D. R. (1995) Biological effects of isoflavones in young women-importance of the chemical composition of soya products. British Journal of Nutrition 74, 587-590.
14. Tang, G. W. K. (1994) The climacteric of Chinese factory workers. Maturitas 19, 177-182.
15. Barnes, S. (1997) The chemopreventive properties of soy isoflavones in animal models of breast cancer. Breast Cancer Research and Treatment 46, 169-179.
16. Petrakis, N. L., Barnes, S., King, E. B., Lowenstein, J., Wiencke, J., Lee, M. M., Miike, R., Kirk, M. and Coward, L. (1996) Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiology, Biomarkers & Prevention 5, 785-794.
17. McMichael-Phillips, D. F., Harding, C., Morton, M., Roberts, S. A., Howell, A., Potten, C. S. and Bundred, N. J. (1998) Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. American Journal of Clinical Nutrition 68, 1431-1436.
18. Lamartiniere, C. A., Moore, J., Holland, M. and Barnes, S. (1995) Neonatal genistein chemoprevents mammary cancer. Proc. Soc. Exp. Biol. Med. 208, 120-123.
19. Goodman, M. T., Wilkens, L. R. and Hankin, J. H. (1997) Association of soy and fiber consumption with the risk of endometrial cancer. American Journal of Epidemiology 146, 294-306.
20. Gustafsson, J.-A. (1999) ERβ - a paradigm shift in estrogen mechanism of action. Estrogens and Women's Health - benefit or threat. Nobel Symposium No. 113 Karlskoga, Sweden (Abstract).
21. Cassidy, A. and Griffin, B. (1999) Phytoestrogens & Cardiovascular disease risk. Proceedings of the Nutrition Society 58, 1-7.
22. Anthony, M. S., Clarkson, T. B., Hughes, C. L., Morgan, D. M. and Burke, G. L. (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. Journal of Nutrition 126, 43-50.
23. Anderson, J. W., Johnstone, B. M. and Cook-Newell, M. E. (1995) Meta-analysis of the effects of soy protein intake on serum lipids. New England Journal of Medicine 333, 276-282.
24. Crouse, J. R., Morgan, T. M., Terry, J. G., Ellis, J., Vitolins, M. and Burke, G. L. (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Archives Internal Medicine 159, 2070-2076.
25. Nevese-eCastro, M., Samsie, G., Doren, M. O. and Skouby, S. (2002) Results from WHI and HERS 11 - implications for women and the prescriber of HRT. Maturitas 42 (4), 255-258.
26. Anderson, J. J. B. and Garner, S. C. (1998) Phytoestrogens and bone. Clinical Endocrinology and Metabolism 12, 543-557.
27. Tobias, J. H., Cook, D. G., Chambers, T. J. and Datzell, N. A. (1994) Comparison of bone mineral density between Caucasian, Asian and Afro-Caribbean women. Clinical Science 87,587-589
28. Ho, S. C. (1996) Body measurements, bone mass and fractures - does the East differ from the West? Clin. Orthop. Relat. Res. 323, 75-80.
29. Cummings, S. R., Cauley, J. A., Palermo, L., Ross, P. D., Wasnich, R. D., Black, D. and Faulkner, K. G. (1994) Racial differences in hip axis lengths might explain differences in rates of hip fracture. Osteoporosis International 4, 226-229.
30. Cassidy, A. (2003) Phytoestrogens and Bone Health. Journal British Menopause Society (in press).
31. Lydeking-Olsen, E., Jensen, J. E. B., Setchell, K. D. R., Damhus, M. and Jensen, T. H. (2001) Isoflavone-rich soymilk prevents bone-loss in the lumbar spine of postmenopausal women. A 2 year study. 4th International Symposium on the role of soy in preventing and treating chronic disease (meeting abstract).
32. Setchell, K. D. R., Zimmer-Nechemias, L., Cai, J. and Heubi, J. E. (1997) Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet 350, 23-27.
33. Setchell, K. D. R., Zimmer-Nechemias, L., Cai, J. and Heubi, J. E. (1998). Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. American Journal of Clinical Nutrition 68, 1453-1461.